publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
annot
influenc
carrier
host
reoviruslik
agent
yet
understood
possibl
infecti
etiolog
bn
support
demonstr
viruslik
particl
renal
biopsi
specimen
three
bn
ptient
well
find
apostolov
colleagu
late
describ
corona
viru
particl
cytoljlasm
renal
cell
obtain
biopsi
patient
clinic
confirm
bn
corona
virus
previous
name
reolik
reoviruslik
difficult
virus
etc
sinc
vitro
serolog
procedur
develop
use
diagnost
tool
diseas
involv
viru
cultiv
tissu
cultur
laboratori
host
littl
known
natur
agent
repetitio
attempt
extens
studi
embrac
modern
techniqu
virolog
prerequisit
progress
field
meanwhil
evid
viral
etiolog
bn
still
entir
morpholog
past
sever
year
numer
studi
involv
digoxin
pharmacokinet
bioavail
reportedl
howev
rel
studi
direct
actual
mechan
digoxin
absorpt
particular
influenc
factor
alter
intestin
motil
transit
time
intestin
diseas
role
enterohepat
circulationi
studi
seem
appar
disturb
normal
gastrointestin
function
might
well
result
signific
alter
digoxm
bioavail
would
like
report
circumst
involv
individu
demonstr
profound
differ
serum
digoxin
level
acut
transient
diarrheal
ill
healthi
male
volunt
receiv
four
rag
digoxin
tablet
lanoxin
burrough
welcom
lot
part
extens
studi
digoxin
absorpt
pharmacokinet
three
hour
ingest
drug
patient
develop
repeat
episod
wateri
diarrhea
persist
throughou
subsequ
hour
total
serial
blood
sampl
drawn
first
hour
follow
singl
blood
sampl
obtain
everi
hour
three
day
six
week
follow
ill
patient
restudi
healthi
state
use
protocol
tablet
lot
serum
digoxin
concentr
determin
duplic
use
radioimmunoassay
schwarzmann
subject
digoxinfre
control
plasma
serv
blank
standard
curv
done
simultan
experiment
sampl
result
serum
level
plot
time
treatment
fig
sinc
patient
involv
larger
studi
involv
intraven
administr
mg
digoxin
possibl
calcul
absolut
bioavail
tablet
area
curv
although
time
reach
peak
serum
level
differ
peak
level
similar
calcul
absolut
bioavail
f
tablet
given
patient
develop
diarrhea
per
cent
substanti
less
drug
administ
normal
circumst
per
cent
despit
fact
studi
involv
singl
dose
digoxin
feel
magnitud
observ
effect
suggest
diarrhea
may
clinic
import
patient
take
digoxin
chronic
basi
although
mechan
respons
dramat
alter
serum
digoxin
level
establish
studi
clearli
result
vomit
incomplet
ingest
tablet
sinc
peak
serum
level
peak
time
appreci
differ
two
studi
initi
absorpt
digoxin
prior
develop
diarrhea
probabl
normal
pronounc
differ
follow
onset
diarrhea
suggest
profound
increas
fecal
elimin
drug
mechan
could
explain
observ
differ
includ
rapid
elimin
undissolv
drug
gastrointestin
tract
alter
intestin
permeabl
increas
secret
digoxin
gastrointestin
tract
interrupt
enterohepat
circul
report
observ
call
attent
fact
acut
diarrhea
appear
mark
influenc
upon
serum
digoxin
level
point
need
studi
fulli
elucid
effect
gastrointestin
disturb
digoxin
elimin
particularli
chronic
digit
patient
confirm
extens
per
cent
case
depend
upon
criteria
recogniz
acut
myocardi
infarct
fatal
first
week
although
may
still
contribut
death
ultim
possibl
prevent
short
term
death
chief
justif
intens
care
resuscit
procedur
aris
increas
attent
number
die
surviv
function
time
elaps
sinc
onset
acut
symptom
short
term
death
alway
instantan
occur
